Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a pre-clinical-stage biotechnology company developing intranasal administrated solutions, today announced the successful production of a ...
Rockville-based biotech company Rise Therapeutics Wednesday announced it has received funding from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at the National ...
Management aims to expand the GMP manufacturing capacity to meet demand from mRNA therapeutics developers and CDMOs, with contracts expected to materialize in the May-June timeframe. The company ...
Dublin, Feb. 12, 2026 (GLOBE NEWSWIRE) -- The "How to Interview During GMP (Good Manufacturing Practice) Audits Training Course (Mar 12, 2026)" training has been added to ResearchAndMarkets.com's ...
ViruSure, an Asahi Kasei company and global leader in pathogen safety testing for biopharmaceuticals, today announced the launch of the world's first GMP-validated adventitious viral agent (AVA) ...
ST. PETERSBURG, Fla., Jan. 7, 2026 /PRNewswire/ -- Health & Beauty Manufacturing (HBM), a U.S.-based contract manufacturer, today announced the formal introduction of its GMP-certified manufacturing ...
Small biotechs in early development of cell therapies are often surprised by the strictness of commercial manufacturing standards. That’s the view of Luděk Sojka, PhD, CEO of contract developer and ...
Manufacturers are usually subjected to a diverse variety of regulations typically established by international and regional bodies. Failure to comply can result in the loss of authorization and ...
Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a pre-clinical-stage biotechnology company developing intranasal administrated solutions, today announced the successful production of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results